Drugs / pegylated formula Interferon-alpha 2b
pegylated formula Interferon-alpha 2b
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00209209 Comparator | Jan 2004 → Dec 2018 | mantle cell lymphoma | European Mantle Cell Lymphoma Network | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | pegylated formula Interferon-alpha 2b | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00209209 ↗ |
| Modality | Protein / enzyme biologic | “cytokine” NCT00209209 ↗ |